Line Lund Kårhus

Dr. Line Lund Kårhus

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2024 in British Journal of Sports Medicine
Verified
Journal Article
Open access
PDF file
PCPieter Coenen
Pieter Coenen
MHMaaike A. Huysmans
Maaike A. Huysmans
AHAndreas Holtermann
Andreas Holtermann
RTRichard P Troiano
Richard P Troiano
PMPaul Jarle Mork
Paul Jarle Mork
ABAllard van der Beek
Allard van der Beek
Objective: Health effects of different physical activity domains (ie, during leisure time, work and transport) are generally considered positive. UsingActive Worker consortiumdata, we assessed independent associations of occupational and leisure-time physical activity (OPA and LTPA) with all-cause mortality.Design: Two-stage individual participant data meta-analysis.Data source: Published and unpublished cohort study data.Eligibility criteria: Working participants aged 18–65 years.Methods: After data harmonisation, we assessed associations of OPA and LTPA with all-cause mortality. In stage 1, we analysed data from each study separately using Cox survival regression, and in stage 2, we pooled individual study findings with random-effects modelling.Results: In 22 studies with up to 590 497 participants from 11 countries, during a mean follow-up of 23.1 (SD: 6.8) years, 99 743 (16%) participants died. Adjusted for LTPA, body mass index, age, smoking and education level, summary (ie, stage 2) hazard ration (HRs) and 95% confidence interval (95% CI) for low, moderate and high OPA among men (n=2 96 134) were 1.01 (0.99 to 1.03), 1.05 (1.01 to 1.10) and 1.12 (1.03 to 1.23), respectively. For women (n=2 94 364), HRs (95% CI) were 0.98 (0.92 to 1.04), 0.96 (0.92 to 1.00) and 0.97 (0.86 to 1.10), respectively. In contrast, higher levels of LTPA were inversely associated with mortality for both genders. For example, for women HR for low, moderate and high compared with sedentary LTPA were 0.85 (0.81 to 0.89), 0.78 (0.74 to 0.81) and 0.75 (0.65 to 0.88), respectively. Effects were attenuated when adjusting for income (although data on income were available from only 9 and 6 studies, for men and women, respectively).Conclusion: Our findings indicate that OPA may not result in the same beneficial health effects as LTPA.

17 February 2015 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Open access
PDF file
AHAnna Horwitz
Anna Horwitz
TSTea Skaaby
Tea Skaaby
LKLine Lund Kårhus
Line Lund Kårhus
Peter SchwarzPeter Schwarz
Peter Schwarz
TJTorben Meinertz Joergensen
Torben Meinertz Joergensen
Allan LinnebergAllan Linneberg
Allan Linneberg
Objective. The prevalence of celiac disease (CD) as recorded in the Danish National Patient Registry is ∼50/100,000 persons. This is much lower than the reported prevalence of CD in other Nordic countries and underdiagnosis is suspected. Our aim was to estimate the prevalence of CD in a population-based study of Danish adults. Methods. A total of 2297 adults aged 24–76 years living in the southwestern part of Copenhagen were screened for CD by immunoglobulin (Ig)A and IgG antibodies to transglutaminases and deamidated gliadin. IgA/IgG-positive participants were invited to a clinical evaluation, including biopsies, by a gastroenterologist. Results. Of the invited 56 participants, 40 underwent a full clinical evaluation and 8 persons were diagnosed with CD; 2 of the 16 persons, who did not complete the clinical evaluation, were considered by experts to have probable CD. None of the above 56 participants had a known history of CD or a recorded diagnosis of CD in National Patient Registry. By combining cases of biopsy-proven CD (n = 8), probable CD (n = 2), and registry-recorded CD (n = 1), the prevalence of CD was estimated to be 479/100,000 (11/2297) persons (95% CI: 197–761). Conclusion. In this general adult population, the prevalence of CD as estimated by screening and clinical evaluation was 10 times higher than the registry-based prevalence of CD. Of 11 participants diagnosed with CD in our screening study, 10 were unaware of the diagnosis prior to the study. Thus, our study suggests that CD is markedly underdiagnosed in Danish adults.

16 June 2020 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
LKLine Lund Kårhus
Line Lund Kårhus
TSTea Skaaby
Tea Skaaby
JPJanne Petersen
Janne Petersen
AMAnja Lykke Madsen
Anja Lykke Madsen
BTBetina Heinsbæk Thuesen
Betina Heinsbæk Thuesen
Allan LinnebergAllan Linneberg
Allan Linneberg
INTRODUCTION: Diagnosed celiac disease (CD) is associated with lymphoproliferative malignancy and gastrointestinal cancer, but little is known about the long-term consequences of undiagnosed CD. We aimed to investigate long-term consequences of undiagnosed CD for mortality and incidence of cancer and other chronic diseases. METHODS: We screened biobank serum samples for immunoglobulin (Ig) A and IgG tissue transglutaminase (TTG) and IgG deamidated gliadin peptide in a study of 8 population-based cohort studies comprising 16,776 participants examined during 1976–2012 and followed with >99% complete follow-up in Danish nationwide registries until December 31, 2017, regarding vital status and incidence of diseases. Undiagnosed CD was defined as antibody positivity (IgA-TTG or IgG-TTG ≥ 7 U/mL and/or IgG deamidated gliadin peptide ≥ 10 U/mL) in individuals without a diagnosis of CD recorded in the National Patient Register. Hazard ratios (HRs) with 95% confidence intervals (CIs) were estimated by Cox regression analyses with age as the underlying time scale. RESULTS: The prevalence of undiagnosed CD was 1.0% with no statistically significant increase over time. Undiagnosed CD was associated with increased risk of cancer overall (HR, 1.57; 95% CI, 1.16–2.11), gastrointestinal cancer (HR, 2.33; 95% CI, 1.35–4.04), cancer of the uterus (HR, 3.95; 95% CI, 1.46–10.69), breast cancer (HR, 1.98; 95% CI, 1.02–3.82), head and neck cancer (HR, 3.12; 95% CI, 1.15–8.43), and cardiovascular disease (HR, 1.37; 95% CI, 1.01–1.85). We found no statistically significant association between undiagnosed CD and mortality (HR, 1.19; 95% CI, 0.87–1.61). DISCUSSION: Undiagnosed CD was associated with increased risk of cardiovascular disease and cancer suggesting that untreated CD has serious long-term health consequences not only affecting the gastrointestinal tract (see Visual Abstract, Supplementary Digital Content, http://links.lww.com/AJG/B566).

1 July 2018 in United European Gastroenterology Journal
Verified
Journal Article
Open access
PDF file
LKLine Lund Kårhus
Line Lund Kårhus
BTBetina H Thuesen
Betina H Thuesen
TSTea Skaaby
Tea Skaaby
JRJüri J Rumessen
Jüri J Rumessen
Allan LinnebergAllan Linneberg
Allan Linneberg
Background: Human leukocyte antigen (HLA) DQ2 and DQ8 are important risk factors for some autoimmune diseases such as celiac disease (CD), but their possible role in other diseases and health conditions is not fully explored.Objectives: The objective of this article is to examine the distribution of HLA DQ2 and HLA DQ8 in an adult general population, and their association with health indicators (diseases, symptoms and biomarkers).Methods: In this cross‐sectional, population‐based study, 2293 individuals were screened for HLA DQ2 and DQ8; CD‐associated alleles (DQA*0201*03*05/DQB*02*0301/0304*0302/0305) and DQB1*02 homozygosity were determined for screen‐positive participants. The National Patient Registry provided diagnosis information.Results: A total of 47.7% (1093/2293) individuals were positive for DQ2 and/or DQ8: 31.2% (716/2293) only DQ2, 11.9% (273/2293) only DQ8, 4.1% (93/2293) both DQ2 and DQ8. Among nine individuals diagnosed with CD, 89.9% (8/9) had DQ2.5cis, 22.2% (2/9) DQ8 and 22.2% (2/9) DQ2.2 (two both DQ2 and DQ8). HLA DQ2.5 was associated with higher thyroid‐stimulating hormone levels, while DQ2/DQ8‐positive participants had significantly lower prevalence of irritable bowel syndrome (IBS). DQ2/DQ8 were strongly associated with CD, but no other registry‐based diagnoses.Conclusion: In this general Danish population, 47.7% were HLA DQ2/DQ8 positive and thus potentially at risk for CD. All individuals with CD were DQ2/DQ8 positive; the majority DQ2.5. Surprisingly, DQ2/DQ8‐positivity was associated with lower IBS prevalence.

28 December 2022 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
LKLine Lund Kårhus
Line Lund Kårhus
SHSusanne Hansen
Susanne Hansen
JRJüri J. Rumessen
Jüri J. Rumessen
Allan LinnebergAllan Linneberg
Allan Linneberg
Background. Coeliac disease affects around 1 of the population, although many cases remain undiagnosed. Underdiagnosis and diagnostic delay in coeliac disease may cause health complications and be a burden for both the patient and society. Casuistic reports indicate that the diagnostic delay may be significant in Danish patients. Aim. To investigate the diagnostic delay among Danish patients with coeliac disease. Methods. We performed a survey among coeliac disease patients to investigate the diagnostic delay. A web-based questionnaire was sent to all members of The Danish Coeliac Society. Results. The questionnaire was completed by 1,392 individuals with a diagnosis of coeliac disease (78.1 women; mean age: 42.8 years). The mean delay was 1.8 (SD 5.0) years from the first symptom to the first health care contact and 5.8 (SD 9.5) years from the first symptom to diagnosis; 18.6 of the participants reported a total diagnostic delay of more than 10 years. Among the patient-reported reasons for delay were misunderstandings, unspecific symptoms, and a lack of knowledge or focus on coeliac disease among the doctors. In total, 52.7 rated the time to diagnosis to have been too long, and 20.1 were not satisfied with the diagnostic process. However, the majority were to some extent or very satisfied with the diagnostic process. Conclusion. We found evidence of a significant diagnostic delay among Danish patients with coeliac disease. This was primarily due to the delay from the time of first health care contact to the time of diagnosis. This study highlights the importance of raising awareness of coeliac disease among health care professionals.

18 October 2012 in Human Reproduction
Verified
Journal Article
Open access
PDF file
LKLine Lund Kårhus
Line Lund Kårhus
PEPia Egerup
Pia Egerup
CSCharlotte Wessel Skovlund
Charlotte Wessel Skovlund
ØLØjvind Lidegaard
Øjvind Lidegaard
How does long-term reproductive prognosis among women whose first pregnancy is ectopic differ from prognosis in women with other initial pregnancy outcomes? Women with a first recorded ectopic pregnancy (EP) have a significantly lower long-term delivery rate and a manifold increased risk of further EPs. Women with a first EP have an increased risk of further EPs. Few studies have assessed long-term reproductive outcomes after an EP, and none was controlled. The study was designed as a historical controlled cohort study. Data were collected from four Danish registries covering the period 1977–2009. Women with an EP as their first recorded pregnancy during the period 1977–1982 were age matched with women whose first recorded pregnancy was a miscarriage, an induced abortion, a delivery, or women with no recorded pregnancies, respectively. The cohorts were followed until the end of 2009 or on average through 30 years. When compared with women with a first miscarriage, women with a first EP had a relative risk of deliveries of 0.55 [95% confidence interval (CI) 0.52–0.58], miscarriages of 0.46 (0.41–0.52) and induced abortions of 0.72 (0.65–0.80) and a 4.7 (3.8–5.8)-fold increased risk of further EPs. The relative delivery rate when compared with women with a first induced abortion was 0.89 (0.84–0.95) and with women with no pregnancy 0.69 (0.65–0.72). We had no information about the attempts to become pregnant in the different cohorts. New fertility techniques may have improved the prognosis among women with a first EP. These results indicate that fertility is compromised in women whose first pregnancy is ectopic. It is possible that better assisted reproductive techniques that have been developed in recent years could improve the long-term delivery rates for women with EP. All the expenses were covered by Gynaecological Clinic, Rigshospitalet. Ø.L. has within the last 3 years received honoraria for speeches in pharmacoepidemiological issues. L.L.K., P.E. and C.W.S. had no conflict of interest to declare.